PCR for Respiratory Infection Diagnostics Market: Key Insights
According to our new research study on “Europe PCR for respiratory infection diagnostics Market Forecast to 2028 - COVID-19 Impact and Analysis - by Type, Product Type, Infection Type, End-user, and Country,” the PCR for respiratory infection diagnostics market was valued at US$ 1,241.01 million in 2021 and is projected to reach US$ 2,432.46 million by 2028; it is expected to grow at a CAGR of 10.1% during 2021-2028. The growth of the market is attributed to increasing burden of chronic respiratory diseases (CRDs) and growing developments for PCR testing.
In 2020, the UK dominated the Europe PCR for respiratory infection diagnostics market. The market growth in the region can be attributed to the factors such as increase in incidence of respiratory tract infections, various international and national players receiving approvals for their PCR sample collection products, rise in government efforts to improve the quality of PCR testing, and increase in product developments by the companies operating in the UK.
Based on type, the PCR for respiratory infection diagnostics market is segmented into real-time PCR (qPCR), traditional PCR, reverse-transcriptase (RT-PCR), digital PCR, multiplex PCR, and others. In 2020, the qPCR accounted for the highest share, and it is expected to dominate the market in the coming future. In terms of product type, the PCR for respiratory infection diagnostics market is segmented into reagents and kits, instruments, and others. The reagents and kits segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period. Based on infection type, the market is divided into bacterial infection, viral infection, and fungal & other pathogens. In 2020, the viral infections segment held the largest share of the market and is estimated to register the highest CAGR in the market during the forecast period. Similarly, based on End-user, the market is divided into hospitals, physician clinics, clinical laboratories, academic and research institutions, biotech and pharma companies, and others. In 2020, the clinical laboratories segment held the largest share of the market and is estimated to register the highest CAGR in the market during the forecast period.
Use of PCR Testing for Various Respiratory Infection Diagnostics to Serve Growth Opportunities to PCR for Respiratory Infection Diagnostics Market.
PCR testing is the gold standard for detecting respiratory infectious diseases, including SARS-CoV-2. Also, the growing developments in PCR are not limited to the COVID-19 testing. The continuous technological developments have allowed researchers to develop advanced PCR techniques at a reduced cost and limit their complexities. It is expected that PCR testing will enhance its capabilities for molecular diagnostics and strengthen its role in the future with the ongoing developments of technologies such as microfluidics and next-generation sequencing. In addition, PCR testing is significantly used in institutions such as nursing homes, chronic care facilities, and hospitals, for identifying influenza virus infection that causes respiratory outbreaks.
Moreover, acute and chronic respiratory infections are among the leading causes of morbidities in the developed and developing countries in Europe and other regions. It is estimated that acute respiratory diseases account for nearly 75% of the total acute morbidities globally. Therefore, various companies are offering various PCR kits that can detect the presence of pathogens that cause respiratory diseases. For instance, companies such as bioMérieux SA and altona Diagnostics GmbH provide a wide range of PCR kits that can detect acute respiratory infection in the upper or lower respiratory tract. Apart from the increasing incidence of acute and chronic respiratory diseases, other factors such as environmental and climatic conditions, air pollution, and discoveries of novel bacteria, viruses, and pathogens are likely to serve as vital growth opportunities for PCR testing for respiratory infection diagnostics in the coming future.
PCR for Respiratory Infection Diagnostics Market: Segmental Overview.
Based on type, the qPCR segment held the largest share of the market in 2020. Real Time PCR is a nuclear-based approach for identifying the presence of specific genetic material in any disease, including viruses. Originally, radioactive isotope markers are used to detect specific genetic elements, but later improvement has resulted in the application of specialized markers, most often fluorescent dyes, to replace isotopic labelling. Real-time PCR has become one of the most extensively used methods of gene quantification because of its enormous dynamic range, remarkable sensitivity, ability to be very sequence-specific, little to no post-amplification processing, and ability to increase sample throughput. However, getting the most out of these benefits necessitates a thorough awareness of the many running options accessible. The ability to identify PCR products in real time, i.e. during the reaction, has been accessible for ten years, but its utilization has skyrocketed in the last two years. PCR-based detection technologies that use species-specific primers are proving to be invaluable as research tools for learning more about the biology of plant/microbe interactions, particularly in terms of the ecology, etiology, and epidemiology of plant pathogenic microorganisms. Several PCR-based technologies for detecting and quantifying mRNA in various organisms have been commercialized in order to meet consumer and regulatory demands. The majority of them are based on the usage of internal transcribed spacer sections within nuclear ribosomal gene clusters, which are particularly appealing nucleus for PCR-based detection assay design. One of the most extensively used laboratory methods for detecting the COVID-19 virus is real-time RT-PCR. While several nations have used real-time RT-PCR to diagnose other diseases such as Ebola and Zika, many more require help in applying this technology to the COVID-19 virus and extending their national testing abilities.
PCR for Respiratory Infection Diagnostics Market: Competition Landscape and Key Developments.
Abbott; F. Hoffmann-La Roche Ltd; Hologic, Inc; BD; Bio-Rad Laboratories Inc; bioMérieux SA; Qiagen N.V; Thermo Fisher Scientific Inc; Seegene Inc; and AusDiagnostics Pty Ltd. are among the key companies operating in the PCR for respiratory infection diagnostics market. Leading players are focusing on the new product launch, expansion and diversification of their market presence, and acquisition of new customer base, thereby tapping prevailing business opportunities.
In January 2021, Allplex SARS-CoV-2/Flu A/Flu B/RSV Assay offered by Seegene Inc. received approval from Korean Ministry of Food and Drug Safety (MFDS). This assay is a multiplex real-time PCR assay for primary screening of N, RdRP, and S genes for SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) A/B in a single tube.
In October 2020, bioMérieux and the Africa Medical Supplies Platform (AMSP) announced a new partnership to facilitate the supply of high-quality diagnostic solutions from the bioMérieux Pandemic Response Portfolio to African Union Member States
In 2020, the UK dominated the Europe PCR for respiratory infection diagnostics market. The market growth in the region can be attributed to the factors such as increase in incidence of respiratory tract infections, various international and national players receiving approvals for their PCR sample collection products, rise in government efforts to improve the quality of PCR testing, and increase in product developments by the companies operating in the UK.
Based on type, the PCR for respiratory infection diagnostics market is segmented into real-time PCR (qPCR), traditional PCR, reverse-transcriptase (RT-PCR), digital PCR, multiplex PCR, and others. In 2020, the qPCR accounted for the highest share, and it is expected to dominate the market in the coming future. In terms of product type, the PCR for respiratory infection diagnostics market is segmented into reagents and kits, instruments, and others. The reagents and kits segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period. Based on infection type, the market is divided into bacterial infection, viral infection, and fungal & other pathogens. In 2020, the viral infections segment held the largest share of the market and is estimated to register the highest CAGR in the market during the forecast period. Similarly, based on End-user, the market is divided into hospitals, physician clinics, clinical laboratories, academic and research institutions, biotech and pharma companies, and others. In 2020, the clinical laboratories segment held the largest share of the market and is estimated to register the highest CAGR in the market during the forecast period.
Use of PCR Testing for Various Respiratory Infection Diagnostics to Serve Growth Opportunities to PCR for Respiratory Infection Diagnostics Market.
PCR testing is the gold standard for detecting respiratory infectious diseases, including SARS-CoV-2. Also, the growing developments in PCR are not limited to the COVID-19 testing. The continuous technological developments have allowed researchers to develop advanced PCR techniques at a reduced cost and limit their complexities. It is expected that PCR testing will enhance its capabilities for molecular diagnostics and strengthen its role in the future with the ongoing developments of technologies such as microfluidics and next-generation sequencing. In addition, PCR testing is significantly used in institutions such as nursing homes, chronic care facilities, and hospitals, for identifying influenza virus infection that causes respiratory outbreaks.
Moreover, acute and chronic respiratory infections are among the leading causes of morbidities in the developed and developing countries in Europe and other regions. It is estimated that acute respiratory diseases account for nearly 75% of the total acute morbidities globally. Therefore, various companies are offering various PCR kits that can detect the presence of pathogens that cause respiratory diseases. For instance, companies such as bioMérieux SA and altona Diagnostics GmbH provide a wide range of PCR kits that can detect acute respiratory infection in the upper or lower respiratory tract. Apart from the increasing incidence of acute and chronic respiratory diseases, other factors such as environmental and climatic conditions, air pollution, and discoveries of novel bacteria, viruses, and pathogens are likely to serve as vital growth opportunities for PCR testing for respiratory infection diagnostics in the coming future.
PCR for Respiratory Infection Diagnostics Market: Segmental Overview.
Based on type, the qPCR segment held the largest share of the market in 2020. Real Time PCR is a nuclear-based approach for identifying the presence of specific genetic material in any disease, including viruses. Originally, radioactive isotope markers are used to detect specific genetic elements, but later improvement has resulted in the application of specialized markers, most often fluorescent dyes, to replace isotopic labelling. Real-time PCR has become one of the most extensively used methods of gene quantification because of its enormous dynamic range, remarkable sensitivity, ability to be very sequence-specific, little to no post-amplification processing, and ability to increase sample throughput. However, getting the most out of these benefits necessitates a thorough awareness of the many running options accessible. The ability to identify PCR products in real time, i.e. during the reaction, has been accessible for ten years, but its utilization has skyrocketed in the last two years. PCR-based detection technologies that use species-specific primers are proving to be invaluable as research tools for learning more about the biology of plant/microbe interactions, particularly in terms of the ecology, etiology, and epidemiology of plant pathogenic microorganisms. Several PCR-based technologies for detecting and quantifying mRNA in various organisms have been commercialized in order to meet consumer and regulatory demands. The majority of them are based on the usage of internal transcribed spacer sections within nuclear ribosomal gene clusters, which are particularly appealing nucleus for PCR-based detection assay design. One of the most extensively used laboratory methods for detecting the COVID-19 virus is real-time RT-PCR. While several nations have used real-time RT-PCR to diagnose other diseases such as Ebola and Zika, many more require help in applying this technology to the COVID-19 virus and extending their national testing abilities.
PCR for Respiratory Infection Diagnostics Market: Competition Landscape and Key Developments.
Abbott; F. Hoffmann-La Roche Ltd; Hologic, Inc; BD; Bio-Rad Laboratories Inc; bioMérieux SA; Qiagen N.V; Thermo Fisher Scientific Inc; Seegene Inc; and AusDiagnostics Pty Ltd. are among the key companies operating in the PCR for respiratory infection diagnostics market. Leading players are focusing on the new product launch, expansion and diversification of their market presence, and acquisition of new customer base, thereby tapping prevailing business opportunities.
In January 2021, Allplex SARS-CoV-2/Flu A/Flu B/RSV Assay offered by Seegene Inc. received approval from Korean Ministry of Food and Drug Safety (MFDS). This assay is a multiplex real-time PCR assay for primary screening of N, RdRP, and S genes for SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) A/B in a single tube.
In October 2020, bioMérieux and the Africa Medical Supplies Platform (AMSP) announced a new partnership to facilitate the supply of high-quality diagnostic solutions from the bioMérieux Pandemic Response Portfolio to African Union Member States
Reasons to buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe PCR for respiratory infection diagnostics market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe PCR for respiratory infection diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe PCR for Respiratory Infection Diagnostics Market - By Type
1.3.2 Europe PCR for Respiratory Infection Diagnostics Market - By Product Type
1.3.3 Europe PCR for Respiratory Infection Diagnostics Market - By Infection Type
1.3.4 Europe PCR for Respiratory Infection Diagnostics Market - By End User
1.3.5 Europe PCR for Respiratory Infection Diagnostics Market - By Geography
2. PCR for Respiratory Infection Diagnostics Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. PCR for Respiratory Infection Diagnostics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe - PEST Analysis
4.3 Expert Opinion
5. PCR for Respiratory Infection Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Burden of Chronic Respiratory Diseases (CRDs)
5.1.2 Growing Developments in PCR Testing
5.2 Market Restraints
5.2.1 Availability of Alternative Assays
5.3 Market Opportunities
5.3.1 Use of PCR Testing for Various Respiratory Infection Diagnostics
5.4 Future Trends
5.4.1 Developments in PCR Technology
5.5 Impact Analysis
6. PCR for Respiratory Infection Diagnostics Market - Regional Analysis
6.1 Europe PCR for Respiratory Infection Diagnostics Market Revenue Forecast And Analysis
6.2 Market Positioning
7. PCR for Respiratory Infection Diagnostics Market Analysis - By Type
7.1 Overview
7.2 PCR for Respiratory Infection Diagnostics Market Revenue Share, by Type (2020 and 2028)
7.3 Real Time PCR
7.3.1 Overview
7.3.2 Real Time PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Multiplex PCR
7.4.1 Overview
7.4.2 Multiplex PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Traditional PCR
7.5.1 Overview
7.5.2 Traditional PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Digital PCR
7.6.1 Overview
7.6.2 Digital PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Reverse Transcriptase (RT-PCR)
7.7.1 Overview
7.7.2 Reverse Transcriptase (RT-PCR): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8. PCR for Respiratory Infection Diagnostics Market Analysis - By Product Type
8.1 Overview
8.2 PCR for Respiratory Infection Diagnostics Market Revenue Share, by Product Type (2020 and 2028)
8.3 Reagents and kits
8.3.1 Reagents and kits: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Instruments
8.4.1 Overview
8.4.2 Instruments: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9. PCR for Respiratory Infection Diagnostics Market - By Infection Type
9.1 Overview
9.2 PCR for Respiratory Infection Diagnostics Market Revenue Share, by Infection Type (2020 and 2028)
9.3 Bacterial Infection
9.3.1 Overview
9.3.2 Bacterial Infection: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.3 Bordetella
9.3.3.1 Overview
9.3.3.2 Bordetella: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.4 Streptococcus Pneumoniae
9.3.4.1 Overview
9.3.4.2 Streptococcus Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.5 Staphylococcus Aureus
9.3.5.1 Overview
9.3.5.2 Staphylococcus Aureus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.6 Haemophilus Influenzae
9.3.6.1 Overview
9.3.6.2 Haemophilus Influenzae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.7 Moraxella Catarrhalis
9.3.7.1 Overview
9.3.7.2 Moraxella Catarrhalis: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.8 Mycoplasma Pneumoniae
9.3.8.1 Overview
9.3.8.2 Mycoplasma Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.9 Chlamydophila Pneumoniae
9.3.9.1 Overview
9.3.9.2 Chlamydophila Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.10 Legionella
9.3.10.1 Overview
9.3.10.2 Legionella: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.11 Others
9.3.11.1 Overview
9.3.11.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4 Viral Infection
9.4.1 Overview
9.4.2 Viral Infection: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.3 Rhinoviruses
9.4.3.1 Overview
9.4.3.2 Rhinoviruses: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.4 Influenza Virus
9.4.4.1 Overview
9.4.4.2 Influenza Virus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.5 Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus
9.4.5.1 Overview
9.4.5.2 Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.6 Respiratory Syncytial Virus (RSV)
9.4.6.1 Overview
9.4.6.2 Respiratory Syncytial Virus (RSV): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.7 Adenovirus
9.4.7.1 Overview
9.4.7.2 Adenovirus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.8 Enterovirus
9.4.8.1 Overview
9.4.8.2 Enterovirus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.9 Parainfluenza
9.4.9.1 Overview
9.4.9.2 Parainfluenza: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.10 Human Metapneumovirus (hMPV)
9.4.10.1 Overview
9.4.10.2 Human Metapneumovirus (hMPV): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.11 Others
9.4.11.1 Overview
9.4.11.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.5 Fungal and Other Pathogens
9.5.1 Overview
9.5.2 Fungal and Other Pathogens: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10. PCR for Respiratory Infection Diagnostics Market - By End User
10.1 Overview
10.2 PCR for Respiratory Infection Diagnostics Market Revenue Share, by End User (2020 and 2028)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.4 Physician Clinics
10.4.1 Overview
10.4.2 Physician Clinics: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.5 Clinical Laboratories
10.5.1 Overview
10.5.2 Clinical Laboratories: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.6 Academic and Research Institutions
10.6.1 Overview
10.6.2 Academic and Research Institutions: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.7 Biotech and Pharma Companies
10.7.1 Overview
10.7.2 Biotech and Pharma Companies: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.8 Others
10.8.1 Overview
10.8.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11. PCR for Respiratory Infection Diagnostics Market - Regional Analysis
11.1 Europe: PCR for Respiratory Infection Diagnostics Market
11.1.1 Overview
11.1.2 Europe: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.3 Europe: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.1.4 Europe: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.1.5 Europe: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.5.1 Europe: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.1.5.2 Europe: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.1.6 Europe: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.1.7 Europe: PCR for Respiratory Infection Diagnostics Market, by Country, 2020 & 2028 (%)
11.1.8 Germany: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.8.1 Germany: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.8.2 Germany: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.1.8.3 Germany: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.1.8.4 Germany: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.8.4.1 Germany: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.1.8.4.2 Germany: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.1.8.5 Germany: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.1.9 UK: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.9.1 UK: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.9.2 UK: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.1.9.3 UK: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.1.9.4 UK: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.9.4.1 UK: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.1.9.4.2 UK: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.1.9.5 UK: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.1.10 Norway: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.10.1 Norway: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.10.2 Norway: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.1.10.3 Norway: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.1.10.4 Norway: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.10.4.1 Norway: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.1.10.4.2 Norway: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.1.10.5 Norway: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.1.11 Netherlands: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.11.1 Netherlands: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.11.2 Netherlands: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.1.11.3 Netherlands: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.1.11.4 Netherlands: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.11.4.1 Netherlands: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.1.11.4.2 Netherlands: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.1.11.5 Netherlands: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.1.12 Rest of Europe: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.12.1 Rest of Europe: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.12.2 Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.1.12.3 Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.1.12.4 Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.12.4.1 Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.1.12.4.2 Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.1.12.5 Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
12. Impact Of COVID-19 Pandemic on PCR for Respiratory Infection Diagnostics Market
12.1 Europe: Impact Assessment of COVID-19 Pandemic
13. PCR For Respiratory Infection Diagnostics Market-Industry Landscape
13.1 Overview
13.2 Growth Strategies in the PCR For Respiratory Infection Diagnostics Market, 2020-2021
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Abbott
14.1.1 ey Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 F. HOFFMANN-LA ROCHE LTD.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Hologic, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 BD
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 BIO-RAD LABORATORIES INC.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 bioMerieux SA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 QIAGEN
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 THERMO FISHER SCIENTIFIC INC.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Seegene Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 AusDiagnostics
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 Glossary of Terms
List of Tables
Table 1. Europe: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 2. Europe: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 3. Europe: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 4. Europe: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 5. Europe: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 6. Europe: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 7. Germany: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 8. Germany: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 9. Germany: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 10. Germany: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 11. Germany: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 12. Germany: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 13. UK: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 14. UK: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 15. UK: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 16. UK: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 17. UK: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 18. UK: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 19. Norway: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 20. Norway: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 21. Norway: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 22. Norway: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 23. Norway: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 24. Norway: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 25. Netherlands: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 26. Netherlands: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 27. Netherlands: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 28. Netherlands: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 29. Netherlands: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 30. Netherlands: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 31. Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 34. Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 35. Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 36. Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 37. Recent Inorganic Growth Strategies in the PCR For Respiratory Infection Diagnostics Market
Table 38. Recent Organic Growth Strategies in the PCR For Respiratory Infection Diagnostics Market
Table 39. Glossary of Terms, PCR for Respiratory Infection Diagnostics MarketList of Figures
Figure 1. PCR for Respiratory Infection Diagnostics Market Segmentation
Figure 2. PCR for Respiratory Infection Diagnostics Market, By Region
Figure 3. Europe PCR for Respiratory Infection Diagnostics Market Overview
Figure 4. Real-Time PCR (qPCR) Segment Held Largest Share of Type Segment In PCR for Respiratory Infection Diagnostics Market
Figure 5. The UK Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe PCR for Respiratory Infection Diagnostics Market, Industry Landscape
Figure 7. Europe PEST Analysis
Figure 8. Expert Opinion
Figure 9. PCR for Respiratory Infection Diagnostics Market Impact Analysis of Drivers and Restraint
Figure 10. Europe PCR for Respiratory Infection Diagnostics Market - Revenue Forecast And Analysis - 2021 - 2028
Figure 11. Europe PCR for Respiratory Infection Diagnostics Market - 2021 - 2028
Figure 12. PCR for Respiratory Infection Diagnostics Market Revenue Share, by Type (2020 and 2028)
Figure 13. Real Time PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Multiplex PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Traditional PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Digital PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Reverse Transcriptase (RT-PCR): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. PCR for Respiratory Infection Diagnostics Market Revenue Share, by Product Type (2020 and 2028)
Figure 20. Reagents and kits: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Instruments: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. PCR for Respiratory Infection Diagnostics Market Share, by Infection Type, 2020 and 2028 (%)
Figure 24. Bacterial Infection: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 25. Bordetella: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 26. Streptococcus Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 27. Staphylococcus Aureus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 28. Haemophilus Influenzae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 29. Moraxella Catarrhalis: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 30. Mycoplasma Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 31. Chlamydophila Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 32. Legionella: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 33. Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 34. Viral Infection: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 35. Rhinoviruses: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 36. Influenza Virus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 37. Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 38. Respiratory Syncytial Virus (RSV): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 39. Adenovirus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 40. Enterovirus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 41. Parainfluenza: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 42. Human Metapneumovirus (hMPV): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 43. Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 44. Fungal and Other Pathogens: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 45. PCR for Respiratory Infection Diagnostics Market Share, by End User, 2020 and 2028 (%)
Figure 46. Hospitals: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 47. Physician Clinics: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 48. Clinical Laboratories: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 49. Academic and Research Institutions: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 50. Biotech and Pharma Companies: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 51. Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 52. Europe: PCR for Respiratory Infection Diagnostics Market, by Key Country - Revenue (2020) (USD Million)
Figure 53. Europe: PCR for Respiratory Infection Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 54. Europe: PCR for Respiratory Infection Diagnostics Market, by Country, 2020 & 2028 (%)
Figure 55. Germany: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 56. UK: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 57. Norway: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 58. Netherlands: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 59. Rest of Europe: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 60. Impact of COVID-19 Pandemic in European Country Markets
Figure 61. Growth Strategies in the PCR For Respiratory Infection Diagnostics Market, 2020-2021
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott
- F. Hoffmann-LA Roche Ltd.
- Hologic, Inc.
- BD
- Bio-Rad Laboratories Inc.
- bioMerieux SA
- Qiagen
- Thermo Fisher Scientific Inc
- Seegene Inc
- AusDiagnostics
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 229 |
| Published | June 2021 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 1241.01 Million |
| Forecasted Market Value ( USD | $ 2432.46 Million |
| Compound Annual Growth Rate | 10.1% |
| Regions Covered | Europe |
